NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Securitas Biosciences Group

Securitas Biosciences Group

São Paulosecuritasbio.com

Overview

Securitas Biosciences Group is a venture studio and holding company founded in 2019 that seeks to invest in molecular and cellular therapies, life sciences applied artificial intelligence, and niche pharma laboratory sectors.

Year Founded

2019

Portfolio Companies

1

Investments

Securitas Biosciences Group investments
CompanyDateStageLead
VirTech BioNov 2022SeedCo-investor

Key People

Luis Claudio Garcia de Souza

Co-Founder Chairman

Hugo Cabrera

Entrepreneur in Residence, Operational Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSão Paulo
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.